Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures

Neurology

Volumn 65, Issue 11, 2005, Pages 1737-1743

  Biton, V ^a   Sackellares, J C ^b   Vuong, A ^c   Hammer, A E ^c   Barrett, P S ^c   Messenheimer, J A ^c  

^a Arkansas Epilepsy Program   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ENZYME INDUCING AGENT; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRIMIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; TRIAZINE DERIVATIVE;

ADOLESCENT; ADULT; APNEA; ARTICLE; CHILD; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DISEASE CLASSIFICATION; DISORIENTATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG OVERDOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC STATE; FEMALE; HEADACHE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PATIENT SELECTION; PRIORITY JOURNAL; RASH; SOMNOLENCE; TONIC CLONIC SEIZURE; URTICARIA; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; ELECTROENCEPHALOGRAPHY; GRAND MAL EPILEPSY; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DISORDERS OF EXCESSIVE SOMNOLENCE; DIZZINESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EPILEPSY, TONIC-CLONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; PATIENT SELECTION; PLACEBOS; TREATMENT OUTCOME; TRIAZINES;

EID: 33645062986     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000187118.19221.e4     Document Type: Article

References (22)

1. Brodie MJ, Richens A, Yuen AWC, et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-479.
2. Steiner TJ, Dellaportas CI, Findley LJ. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40:601-607.
3. Lerman-Sagie T, Lerman P. Dramatic effect of lamotrigine in young adults suffering from intractable absences and generalized tonic-clonic seizures since childhood. J Epilepsy 1998;11:148-151.
4. Mikati MA, Holmes GL. Lamotrigine in absence and primary generalized epilepsies. J Child Neurol 1997;12 (suppl 1):S29-S37.
5. Buchanan N. Lamotrigine: clinical experience in 200 patients with epilepsy with follow-up to four years. Seizures 1996;5:209-214.
6. Casaubon L, Pohlmann-Eden B, Khosravani H, et al. Video-EEG evidence of lateralized clinical features in primary generalized epilepsy with tonic-clonic seizures. Epileptic Disord 2003;5:149-156.
7. Brodie MJ, Chadwick DW, Anhut H, et al. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002;43:993-1000.
8. Dimova PS, Korinthenberg R. Efficacy of lamotrigine and vigabatrin in drug-resistant epilepsies of childhood. Pediatr Neurol 1999;21:802-807.
9. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1989;30:389-399.
10. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 1999;52:1330-1337.
11. Topiramate Summary Basis of Approval. Center for Drug Evaluation and Research Application Number 20505, S001. Medical Reviews. Available at: www.fda.gov/cder/foi/nda/99/20505S1_Topamax_medr_ P1.pdf. Accessed January 14, 2005.
12. Chadwick D, Leiderman DB, Sauermann W, et al. Gabapentin in generalized seizures. Epilepsy Res 1996;1996:191-197.
13. Jawad S, Richens A, Goodwin G, et al. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989;30:356-363.
14. Sander JWAS, Patsalos PN, Oxley JR, et al. A randomized, double-blind, placebo-controlled, add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990;6:221-226.
15. Loiseau P, Yuen AWC, Duche B, et al. A randomized double-blind crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res 1990;7:136-145.
16. Schapel GJ, Beran RG, Vajda FJE, et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant partial seizures. J Neurol Neurosurg Psychiatry 1993;56:448-453.
17. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284-2291.
18. Messenheimer JA, Ramsay RE, Eilmore LJ, et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, crossover trial. Epilepsia 1994;35:1113-1121.
19. Gilliam F, Vazquez B, Sackellares JC, et al. An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 1998;51:1018-1025.
20. Buoni S, Grosso S, Fois A. Lamotrigine in typical absence epilepsy. Brain Dev 1999;21:303-306.
21. Motte J, Trevathan E, Arvidsson JFV, et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1998;337:1807-1812.
22. Frank LM, Enlow T, Holmes GL, et al. Lamictal monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-979.